{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:51:40Z","timestamp":1788299500513,"version":"build-2803163510"},"reference-count":26,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/ijmm.2016.2766","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T06:42:58Z","timestamp":1475476978000},"page":"1499-1506","source":"Crossref","is-referenced-by-count":42,"title":["Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice"],"prefix":"10.3892","volume":"38","author":[{"given":"Keisuke","family":"Yokohama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fukunishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideko","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"key20180107232246_b1-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180107232246_b2-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20180107232246_b3-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"key20180107232246_b4-ijmm-38-05-1499","first-page":"272","article-title":"Atrovastatin and gemfibrozil metabolities, but not the parent drugs are potent antioxidants against lipoprotein oxidation","volume":"138","author":"Aviram","year":"1998","journal-title":"Antherosclerosis"},{"key":"key20180107232246_b5-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107232246_b6-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"key20180107232246_b7-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/dmd.30.11.1158","article-title":"Liver-specific distribution of rosuvastatin in rats: Comparison with pravastatin and simvastatin","volume":"30","author":"Nezasa","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"key20180107232246_b8-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00005344-200304000-00019","article-title":"Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats","volume":"41","author":"Ikeda","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"key20180107232246_b9-ijmm-38-05-1499","first-page":"S11","article-title":"Rosuvastatin protects the myocardium against ischaemia-reperfusion injury via inhibition of GGPP synthesis","volume":"15","author":"Bulhak","year":"2004","journal-title":"Cardiovasc J S Afr"},{"key":"key20180107232246_b10-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.00962.2004","article-title":"Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion","volume":"288","author":"Weinberg","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20180107232246_b11-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-201X.2004.01392.x","article-title":"Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia\/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level","volume":"183","author":"Bulhak","year":"2005","journal-title":"Acta Physiol Scand"},{"key":"key20180107232246_b12-ijmm-38-05-1499","first-page":"4849","article-title":"Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice","volume":"34","author":"Takakura","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180107232246_b13-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.gastro.2010.05.018","article-title":"Innate immunity and steatohepatitis: A critical role of another toll (TLR-9)","volume":"139","author":"Gao","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180107232246_b14-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107232246_b15-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2337\/diabetes.54.5.1331","article-title":"Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver","volume":"54","author":"Foretz","year":"2005","journal-title":"Diabetes"},{"key":"key20180107232246_b16-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"2455S","DOI":"10.1093\/jn\/134.9.2455S","article-title":"Leptin and the control of metabolism: Role for stearoyl-CoA desaturase-1 (SCD-1)","volume":"134","author":"Cohen","year":"2004","journal-title":"J Nutr"},{"key":"key20180107232246_b17-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1566524033479537","article-title":"Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis","volume":"3","author":"Yu","year":"2003","journal-title":"Curr Mol Med"},{"key":"key20180107232246_b18-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev"},{"key":"key20180107232246_b19-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"The cellular basis of hepatic fibrosis. Mechanism and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"key20180107232246_b20-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107232246_b21-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2008.03857.x","article-title":"Review article: Pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents","volume":"28","author":"Chaparro","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180107232246_b22-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2010.05.009","article-title":"Sorafenib exerts anti-glioma activity in vitro and in vivo","volume":"478","author":"Siegelin","year":"2010","journal-title":"Neurosci Lett"},{"key":"key20180107232246_b23-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/MCB.13.8.4753","article-title":"ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation","volume":"13","author":"Tontonoz","year":"1993","journal-title":"Mol Cell Biol"},{"key":"key20180107232246_b24-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-1033.1997.00259.x","article-title":"The AMP-activated protein kinase\u2013fuel gauge of the mammalian cell?","volume":"246","author":"Hardie","year":"1997","journal-title":"Eur J Biochem"},{"key":"key20180107232246_b25-ijmm-38-05-1499","first-page":"E1","article-title":"AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes","volume":"277","author":"Winder","year":"1999","journal-title":"Am J Physiol"},{"key":"key20180107232246_b26-ijmm-38-05-1499","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2008.10.031","article-title":"Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice","volume":"50","author":"Ishii","year":"2009","journal-title":"J Hepatol"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2016.2766\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T22:21:51Z","timestamp":1749594111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2016.2766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,10,3]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/ijmm.2016.2766"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2016.2766","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]}}}